ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 92 filers reported holding ADMA BIOLOGICS INC in Q1 2020. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,501,238 | +1.0% | 419,340 | +4.1% | 0.00% | – |
| Q2 2023 | $1,485,985 | +21.4% | 402,706 | +8.9% | 0.00% | – |
| Q1 2023 | $1,224,243 | -14.7% | 369,862 | -0.1% | 0.00% | – |
| Q4 2022 | $1,436,000 | +57.8% | 370,232 | -1.0% | 0.00% | – |
| Q3 2022 | $910,000 | +19.1% | 374,156 | -3.0% | 0.00% | – |
| Q2 2022 | $764,000 | +1636.4% | 385,573 | +1701.7% | 0.00% | – |
| Q4 2020 | $44,000 | -62.1% | 21,400 | -56.0% | 0.00% | – |
| Q3 2020 | $116,000 | -14.7% | 48,680 | +4.9% | 0.00% | – |
| Q2 2020 | $136,000 | +46.2% | 46,410 | +43.7% | 0.00% | – |
| Q1 2020 | $93,000 | -1.1% | 32,300 | +36.9% | 0.00% | – |
| Q4 2019 | $94,000 | -54.1% | 23,600 | -48.7% | 0.00% | – |
| Q3 2019 | $205,000 | +7.3% | 46,005 | -6.9% | 0.00% | – |
| Q2 2019 | $191,000 | – | 49,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 9,104,275 | $32,593,305 | 10.83% |
| Altium Capital Management LP | 2,723,011 | $9,748,379 | 5.08% |
| Velan Capital Investment Management LP | 1,736,100 | $6,215,238 | 5.01% |
| AWM Investment Company, Inc. | 5,999,872 | $21,479,542 | 3.17% |
| Mesirow Financial Investment Management, Inc. | 72,677 | $260,184 | 1.13% |
| Caligan Partners LP | 597,513 | $2,139,097 | 0.98% |
| Perceptive Advisors | 6,984,319 | $25,003,862 | 0.83% |
| OBERWEIS ASSET MANAGEMENT INC/ | 2,078,400 | $7,440,672 | 0.79% |
| TANG CAPITAL MANAGEMENT LLC | 1,360,000 | $4,868,800 | 0.69% |
| EAM Investors, LLC | 967,146 | $3,462,383 | 0.67% |